Skip to content
★ Sign in to follow
SN

Steven N. Dupont

Pharmion Corp
Total declarations
18
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (11 ops.)
€310k

Latest filing published 12 Mar 2008 for PHARMION CORP, €78k.

Insider track record

Disclosed buys
0
Disclosed sells
11
Signal history

No signal scores available.

Steven N. Dupont: trading record in brief

Steven N. Dupont appears in our data through filings on Pharmion Corp shares, published by SEC (Form 4). Over a trading history stretching from 6 August 2007 to 7 March 2008, the count stands at 18 filings.

The open-market record consists of 11 sales worth €310k, with no purchase. Besides market trades, the filings include 2 share grants and 4 option exercises.

The newest entry dates from 12 March 2008: an option exercise of €78k, in Pharmion Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Steven N. Dupont

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total
  • ◇
    EVP and General CounselExecutivesPharmion Corp
    119,609 USD0SEC
    1,650 shares@ US$72.49Common StockSEC:0001209191-08-017839:0
  • ◆
    EVP and General CounselExecutivesPharmion Corp
    0SEC
    513 sharesCommon StockSEC:0001209191-08-017839:1
  • ●
    EVP and General CounselExecutivesPharmion Corp
    0SEC
    4,267 sharesCommon StockSEC:0001209191-08-017839:2
  • ◇
    EVP, General CounselExecutivesPharmion Corp
    50,848 USD0SEC
    2,750 shares@ US$18.49Common StockSEC:0001209191-08-015792:0
  • ◇
    Executive VP, General CounselExecutivesPharmion Corp
    35,189 USD0SEC
    550 shares@ US$63.98Common StockSEC:0001209191-07-068588:0
  • ◆
    Executive VP, General CounselExecutivesPharmion Corp
    10,877 USD0SEC
    170 shares@ US$63.98Common StockSEC:0001209191-07-068588:1
  • ◇
    VP, General CounselExecutivesPharmion Corp
    184,900 USD0SEC
    10,000 shares@ US$18.49Common StockSEC:0001209191-07-046611:0
  • ▼
    VP, General CounselExecutivesPharmion Corp
    213,511 USD0SEC
    5,012 shares@ US$42.60Common StockSEC:0001209191-07-046611:1
  • ▼
    VP, General CounselExecutivesPharmion Corp
    136,448 USD0SEC
    3,200 shares@ US$42.64Common StockSEC:0001209191-07-046611:2
  • ▼
    VP, General CounselExecutivesPharmion Corp
    4,265 USD0SEC
    100 shares@ US$42.65Common StockSEC:0001209191-07-046611:3
  • ▼
    VP, General CounselExecutivesPharmion Corp
    4,267 USD0SEC
    100 shares@ US$42.67Common StockSEC:0001209191-07-046611:4
  • ▼
    VP, General CounselExecutivesPharmion Corp
    8,536 USD0SEC
    200 shares@ US$42.68Common StockSEC:0001209191-07-046611:5
  • ▼
    VP, General CounselExecutivesPharmion Corp
    9,306 USD0SEC
    218 shares@ US$42.69Common StockSEC:0001209191-07-046611:6
  • ▼
    VP, General CounselExecutivesPharmion Corp
    8,542 USD0SEC
    200 shares@ US$42.71Common StockSEC:0001209191-07-046611:7
  • ▼
    VP, General CounselExecutivesPharmion Corp
    8,971 USD0SEC
    210 shares@ US$42.72Common StockSEC:0001209191-07-046611:8
  • ▼
    VP, General CounselExecutivesPharmion Corp
    8,548 USD0SEC
    200 shares@ US$42.74Common StockSEC:0001209191-07-046611:9
  • ▼
    VP, General CounselExecutivesPharmion Corp
    17,100 USD0SEC
    400 shares@ US$42.75Common StockSEC:0001209191-07-046611:10
  • ▼
    VP, General CounselExecutivesPharmion Corp
    6,845 USD0SEC
    160 shares@ US$42.78Common StockSEC:0001209191-07-046611:11

18 of 18 declarations